ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Policy

CAS holds innovation meeting in Shanghai

by Jean-François Tremblay
January 23, 2017 | APPEARED IN VOLUME 95, ISSUE 4

CAS, a division of the American Chemical Society, held its second annual Innovation Summit at the Zhangjiang Hi-Tech Park in Shanghai on Nov. 16. The meeting focused on drug discovery and development strategies for Chinese pharmaceutical and biotech firms. The speakers included Yang Ye, deputy director of the Shanghai Institute of Materia Medica, and Haijun Dong, chief executive officer of the custom chemistry firm PharmaBlock Science.

Attendees also heard from T.J. Deng, China managing director of the U.S. contract research firm BioDuro. Deng described the services that his firm could offer to Chinese clients.

Announcements of ACS news can be sent to acsnews.cen@acs.org.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment